Gene Symbol | Gene ID | Gene Info |
---|---|---|
Maz
|
ENSMUSG00000030678.6 | MYC-associated zinc finger protein (purine-binding transcription factor) |
Zfp281
|
ENSMUSG00000041483.8 | zinc finger protein 281 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_127026886_127027456 | Maz | 134 | 0.826187 | -0.35 | 6.0e-03 | Click! |
chr7_127026554_127026705 | Maz | 57 | 0.894476 | -0.20 | 1.2e-01 | Click! |
chr7_127026175_127026502 | Maz | 114 | 0.863718 | -0.17 | 2.0e-01 | Click! |
chr7_127024876_127025027 | Maz | 181 | 0.808762 | 0.09 | 4.8e-01 | Click! |
chr7_127025097_127026155 | Maz | 494 | 0.477392 | -0.08 | 5.2e-01 | Click! |
chr1_136624931_136625115 | Zfp281 | 122 | 0.776023 | -0.51 | 2.9e-05 | Click! |
chr1_136625136_136625289 | Zfp281 | 311 | 0.654132 | -0.46 | 2.4e-04 | Click! |
chr1_136626899_136627050 | Zfp281 | 2073 | 0.203561 | 0.41 | 1.0e-03 | Click! |
chr1_136625344_136625935 | Zfp281 | 738 | 0.433505 | -0.10 | 4.4e-01 | Click! |
chr1_136627064_136628062 | Zfp281 | 2662 | 0.175265 | 0.10 | 4.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_116590520_116593206 | 32.13 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr17_12636042_12637507 | 18.44 |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
15934 |
0.17 |
chr12_75176309_75177605 | 17.75 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
375 |
0.92 |
chr2_178141581_178143125 | 17.50 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr10_81472751_81473777 | 17.11 |
Celf5 |
CUGBP, Elav-like family member 5 |
114 |
0.9 |
chr4_139832357_139834219 | 15.75 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr13_83732205_83734272 | 15.48 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr3_8509825_8511666 | 15.45 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr7_44441951_44442938 | 15.40 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr19_6418703_6419936 | 15.29 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr11_96347886_96350398 | 15.07 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chr5_37241461_37244349 | 14.22 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr3_94478073_94479450 | 14.04 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr3_88206822_88208169 | 13.78 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr9_91366433_91367646 | 13.72 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1229 |
0.26 |
chr12_117153278_117156362 | 13.61 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr2_105680581_105683424 | 13.57 |
Pax6 |
paired box 6 |
290 |
0.89 |
chr13_42709652_42710400 | 13.44 |
Phactr1 |
phosphatase and actin regulator 1 |
445 |
0.88 |
chr2_70561988_70564432 | 13.34 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr1_158362036_158363261 | 13.29 |
Astn1 |
astrotactin 1 |
98 |
0.97 |
chr7_43489310_43490670 | 13.18 |
Iglon5 |
IgLON family member 5 |
85 |
0.92 |
chr2_109677166_109678631 | 13.14 |
Bdnf |
brain derived neurotrophic factor |
866 |
0.48 |
chr9_22050521_22051976 | 13.11 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr3_34662808_34665047 | 13.08 |
Gm42693 |
predicted gene 42693 |
362 |
0.74 |
chr4_140245362_140247262 | 13.03 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr15_89453545_89454765 | 12.93 |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
242 |
0.82 |
chr11_55607331_55608633 | 12.74 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr7_45785390_45787192 | 12.72 |
Lmtk3 |
lemur tyrosine kinase 3 |
266 |
0.77 |
chrX_170674573_170675954 | 12.68 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr7_126823319_126824529 | 12.66 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr14_28508967_28511864 | 12.63 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr3_34652462_34653573 | 12.62 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr7_3390544_3391386 | 12.34 |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
282 |
0.73 |
chr3_34648572_34651394 | 12.31 |
Sox2 |
SRY (sex determining region Y)-box 2 |
422 |
0.73 |
chr8_94994139_94995207 | 11.93 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr14_66344363_66345813 | 11.91 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr15_98989928_98991865 | 11.71 |
4930578M01Rik |
RIKEN cDNA 4930578M01 gene |
5002 |
0.1 |
chr3_31309226_31310664 | 11.68 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr4_154635108_154637998 | 11.59 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr7_70347472_70349327 | 11.37 |
Gm44948 |
predicted gene 44948 |
703 |
0.54 |
chr4_127988222_127989180 | 11.15 |
Csmd2 |
CUB and Sushi multiple domains 2 |
657 |
0.77 |
chr17_93198991_93201483 | 11.15 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr3_17793835_17795104 | 11.13 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr12_110187430_110189676 | 11.00 |
Gm34785 |
predicted gene, 34785 |
492 |
0.73 |
chr6_114282516_114283979 | 10.97 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr1_72826047_72827238 | 10.96 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
1320 |
0.5 |
chr2_180890379_180892235 | 10.91 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr6_77978407_77979215 | 10.87 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
739 |
0.71 |
chr8_12400578_12402091 | 10.85 |
Gm25239 |
predicted gene, 25239 |
4931 |
0.15 |
chr4_101549898_101551379 | 10.76 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
44 |
0.98 |
chr9_69758963_69761490 | 10.66 |
Foxb1 |
forkhead box B1 |
714 |
0.5 |
chr1_132541040_132543287 | 10.61 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr6_93911862_93913573 | 10.57 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr2_74725879_74728683 | 10.56 |
Hoxd4 |
homeobox D4 |
207 |
0.67 |
chr2_31638722_31641540 | 10.52 |
Prdm12 |
PR domain containing 12 |
94 |
0.84 |
chr15_98003545_98005314 | 10.48 |
Col2a1 |
collagen, type II, alpha 1 |
62 |
0.97 |
chr5_120321916_120323112 | 10.39 |
Gm42654 |
predicted gene 42654 |
20045 |
0.16 |
chr5_36868663_36870303 | 10.39 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr9_106147912_106149765 | 10.36 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr5_114090407_114091746 | 10.35 |
Svop |
SV2 related protein |
291 |
0.84 |
chr15_78119178_78120215 | 10.35 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
10 |
0.83 |
chr7_37771594_37773731 | 10.33 |
Zfp536 |
zinc finger protein 536 |
213 |
0.95 |
chr7_44592789_44594513 | 10.27 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
344 |
0.69 |
chr3_88208985_88210116 | 10.27 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr2_105678552_105679922 | 10.12 |
Pax6 |
paired box 6 |
630 |
0.68 |
chr18_35964551_35965976 | 10.12 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
158 |
0.94 |
chr5_120426818_120428597 | 10.04 |
Lhx5 |
LIM homeobox protein 5 |
3992 |
0.15 |
chrX_7638310_7639997 | 9.99 |
Syp |
synaptophysin |
152 |
0.88 |
chr2_29845262_29846623 | 9.94 |
Mir219a-2 |
microRNA 219a-2 |
215 |
0.56 |
chr4_22491084_22492166 | 9.93 |
Gm30731 |
predicted gene, 30731 |
1077 |
0.46 |
chr3_87947557_87949450 | 9.92 |
Crabp2 |
cellular retinoic acid binding protein II |
163 |
0.9 |
chrX_150656320_150657724 | 9.88 |
Tro |
trophinin |
350 |
0.85 |
chr2_109673568_109674815 | 9.88 |
Bdnf |
brain derived neurotrophic factor |
509 |
0.64 |
chr10_90828879_90830154 | 9.85 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
50 |
0.97 |
chr17_85614150_85615720 | 9.81 |
Six3os1 |
SIX homeobox 3, opposite strand 1 |
413 |
0.73 |
chr9_58197310_58202560 | 9.76 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr7_79498955_79500626 | 9.74 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr7_24485614_24487418 | 9.74 |
Cadm4 |
cell adhesion molecule 4 |
4493 |
0.1 |
chr8_70119024_70120981 | 9.68 |
Ncan |
neurocan |
871 |
0.35 |
chr14_67236008_67239452 | 9.64 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr19_45230983_45235468 | 9.64 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr5_115429732_115430910 | 9.64 |
Msi1 |
musashi RNA-binding protein 1 |
284 |
0.71 |
chr4_25799045_25800424 | 9.63 |
Fut9 |
fucosyltransferase 9 |
121 |
0.96 |
chr14_64588312_64589438 | 9.62 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr15_85576096_85578271 | 9.56 |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
887 |
0.54 |
chr6_136172206_136173574 | 9.54 |
Gm26653 |
predicted gene, 26653 |
171 |
0.59 |
chr13_83727321_83728283 | 9.53 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
304 |
0.83 |
chr2_136050884_136052422 | 9.49 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
586 |
0.78 |
chrX_135210129_135210918 | 9.45 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
164 |
0.93 |
chr3_108410436_108412210 | 9.43 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr4_125490136_125491914 | 9.40 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
325 |
0.89 |
chr5_115431565_115432258 | 9.32 |
Msi1 |
musashi RNA-binding protein 1 |
1306 |
0.22 |
chr1_93175979_93177278 | 9.31 |
Crocc2 |
ciliary rootlet coiled-coil, rootletin family member 2 |
7903 |
0.13 |
chr13_109116105_109117683 | 9.30 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
253 |
0.96 |
chr15_76519928_76521866 | 9.28 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr17_54297811_54299023 | 9.26 |
Slc5a7 |
solute carrier family 5 (choline transporter), member 7 |
39 |
0.98 |
chr1_78201086_78202244 | 9.17 |
Pax3 |
paired box 3 |
4531 |
0.25 |
chr5_112228060_112229152 | 9.05 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
35 |
0.96 |
chr3_89226055_89227441 | 8.99 |
Mtx1 |
metaxin 1 |
304 |
0.42 |
chr8_93812106_93812875 | 8.96 |
Gnao1 |
guanine nucleotide binding protein, alpha O |
1177 |
0.35 |
chr12_117807954_117808128 | 8.94 |
Cdca7l |
cell division cycle associated 7 like |
3752 |
0.26 |
chr8_17534365_17535810 | 8.94 |
Csmd1 |
CUB and Sushi multiple domains 1 |
194 |
0.97 |
chr3_88537757_88539123 | 8.93 |
Mir1905 |
microRNA 1905 |
2058 |
0.13 |
chr2_74749244_74750558 | 8.92 |
Haglr |
Hoxd antisense growth associated long non-coding RNA |
605 |
0.44 |
chr17_28145328_28147472 | 8.88 |
Scube3 |
signal peptide, CUB domain, EGF-like 3 |
3874 |
0.13 |
chr2_158614356_158617139 | 8.86 |
Gm14205 |
predicted gene 14205 |
3927 |
0.13 |
chr6_110645148_110646464 | 8.86 |
Gm20387 |
predicted gene 20387 |
110 |
0.67 |
chr9_106456260_106457377 | 8.85 |
Pcbp4 |
poly(rC) binding protein 4 |
721 |
0.42 |
chr18_77560987_77561705 | 8.85 |
Rnf165 |
ring finger protein 165 |
3263 |
0.29 |
chr9_61384680_61386184 | 8.85 |
Tle3 |
transducin-like enhancer of split 3 |
9903 |
0.19 |
chr6_45059551_45060577 | 8.85 |
Cntnap2 |
contactin associated protein-like 2 |
3 |
0.98 |
chr13_53469792_53470715 | 8.83 |
Msx2 |
msh homeobox 2 |
2821 |
0.27 |
chr17_85616568_85618863 | 8.83 |
Six3os1 |
SIX homeobox 3, opposite strand 1 |
358 |
0.81 |
chr14_4334314_4335468 | 8.80 |
2610042L04Rik |
RIKEN cDNA 2610042L04 gene |
128 |
0.95 |
chr7_137309191_137310700 | 8.78 |
Ebf3 |
early B cell factor 3 |
3971 |
0.23 |
chr1_173366699_173367980 | 8.78 |
Cadm3 |
cell adhesion molecule 3 |
294 |
0.89 |
chr14_52310870_52313267 | 8.75 |
Sall2 |
spalt like transcription factor 2 |
4255 |
0.1 |
chr11_42419852_42421693 | 8.74 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
507 |
0.88 |
chr5_27048872_27050274 | 8.70 |
Dpp6 |
dipeptidylpeptidase 6 |
180 |
0.97 |
chr14_52009953_52011160 | 8.69 |
Zfp219 |
zinc finger protein 219 |
19 |
0.94 |
chr19_5096057_5096487 | 8.69 |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
2110 |
0.12 |
chr1_19213854_19215338 | 8.68 |
Tfap2b |
transcription factor AP-2 beta |
717 |
0.69 |
chr14_3651660_3652927 | 8.67 |
Gm3020 |
predicted gene 3020 |
263 |
0.87 |
chr18_43686487_43688415 | 8.65 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr14_119123052_119124306 | 8.65 |
Hs6st3 |
heparan sulfate 6-O-sulfotransferase 3 |
14662 |
0.18 |
chr18_59062200_59063436 | 8.65 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr2_32741082_32742388 | 8.61 |
Sh2d3c |
SH2 domain containing 3C |
243 |
0.72 |
chr7_44336079_44337576 | 8.59 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr7_4119233_4120703 | 8.59 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr11_107793364_107794626 | 8.58 |
Gm11650 |
predicted gene 11650 |
129 |
0.87 |
chr1_109982396_109983459 | 8.56 |
Cdh7 |
cadherin 7, type 2 |
54 |
0.99 |
chr2_116061308_116062718 | 8.54 |
Meis2 |
Meis homeobox 2 |
347 |
0.86 |
chr18_23038815_23040349 | 8.53 |
Nol4 |
nucleolar protein 4 |
496 |
0.88 |
chr14_5148637_5149909 | 8.52 |
Gm3317 |
predicted gene 3317 |
15262 |
0.11 |
chr5_37245879_37246957 | 8.50 |
Crmp1 |
collapsin response mediator protein 1 |
573 |
0.76 |
chr14_4726384_4727541 | 8.46 |
Gm3252 |
predicted gene 3252 |
187 |
0.91 |
chr2_146834060_146838027 | 8.40 |
Gm14114 |
predicted gene 14114 |
3689 |
0.27 |
chr7_18925442_18925859 | 8.39 |
Nova2 |
NOVA alternative splicing regulator 2 |
238 |
0.86 |
chr3_88214322_88216234 | 8.38 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr2_181313043_181314281 | 8.38 |
Stmn3 |
stathmin-like 3 |
838 |
0.42 |
chr14_122472255_122473599 | 8.37 |
2610035F20Rik |
RIKEN cDNA 2610035F20 gene |
652 |
0.55 |
chr6_127768524_127769705 | 8.36 |
Prmt8 |
protein arginine N-methyltransferase 8 |
358 |
0.74 |
chr2_136711813_136712965 | 8.19 |
Snap25 |
synaptosomal-associated protein 25 |
1064 |
0.55 |
chr14_4498814_4499998 | 8.16 |
Gm3173 |
predicted gene 3173 |
15352 |
0.11 |
chr4_134019273_134020476 | 8.15 |
Lin28a |
lin-28 homolog A (C. elegans) |
1033 |
0.34 |
chr10_84756349_84757352 | 8.13 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
788 |
0.69 |
chr15_75565940_75567228 | 8.12 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
48 |
0.96 |
chr1_166255711_166256817 | 8.11 |
Ildr2 |
immunoglobulin-like domain containing receptor 2 |
2071 |
0.3 |
chr13_56582551_56582734 | 8.11 |
2010203P06Rik |
RIKEN cDNA 2010203P06 gene |
12895 |
0.17 |
chr2_152080491_152081480 | 8.08 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr6_83185720_83187846 | 8.08 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr1_124045018_124046369 | 8.08 |
Dpp10 |
dipeptidylpeptidase 10 |
134 |
0.98 |
chr18_21652640_21654059 | 8.07 |
4930426D05Rik |
RIKEN cDNA 4930426D05 gene |
786 |
0.51 |
chr7_25004827_25006284 | 8.07 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr14_5501278_5502453 | 8.05 |
Gm3488 |
predicted gene, 3488 |
191 |
0.9 |
chr2_136713069_136714459 | 8.04 |
Snap25 |
synaptosomal-associated protein 25 |
286 |
0.92 |
chr14_7314401_7315446 | 8.03 |
Gm3739 |
predicted gene 3739 |
126 |
0.95 |
chr14_6889307_6890296 | 8.00 |
Gm3667 |
predicted gene 3667 |
161 |
0.95 |
chr4_22477149_22478263 | 7.99 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
10660 |
0.16 |
chr11_108923092_108924343 | 7.99 |
Axin2 |
axin 2 |
536 |
0.8 |
chr13_96131908_96133176 | 7.97 |
Sv2c |
synaptic vesicle glycoprotein 2c |
35 |
0.94 |
chr2_91930544_91931926 | 7.95 |
Mdk |
midkine |
453 |
0.69 |
chr16_5884597_5886147 | 7.94 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr9_91363965_91365514 | 7.94 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1029 |
0.35 |
chr6_127766683_127768449 | 7.90 |
Gm42738 |
predicted gene 42738 |
24 |
0.95 |
chr14_3412245_3413254 | 7.89 |
Gm10409 |
predicted gene 10409 |
135 |
0.93 |
chr6_126644051_126646029 | 7.87 |
Kcna1 |
potassium voltage-gated channel, shaker-related subfamily, member 1 |
227 |
0.94 |
chr5_24321335_24322296 | 7.87 |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
439 |
0.73 |
chr5_37028040_37029531 | 7.87 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
327 |
0.87 |
chr10_106469534_106470969 | 7.86 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
88 |
0.97 |
chr2_172549301_172551909 | 7.86 |
Tfap2c |
transcription factor AP-2, gamma |
48 |
0.98 |
chr5_103210548_103211780 | 7.86 |
Mapk10 |
mitogen-activated protein kinase 10 |
109 |
0.98 |
chr5_30104769_30106082 | 7.85 |
3110082J24Rik |
RIKEN cDNA 3110082J24 gene |
66 |
0.75 |
chr13_78197747_78198667 | 7.83 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
190 |
0.6 |
chr14_66910135_66911764 | 7.82 |
Pnma2 |
paraneoplastic antigen MA2 |
221 |
0.91 |
chr4_115133068_115134495 | 7.81 |
Cyp4x1os |
cytochrome P450, family 4, subfamily x, polypeptide 1, opposite strand |
51 |
0.69 |
chr7_46179165_46180456 | 7.81 |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
176 |
0.92 |
chr8_121118797_121121438 | 7.79 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr6_42323611_42324574 | 7.75 |
Fam131b |
family with sequence similarity 131, member B |
500 |
0.63 |
chr2_85197983_85199004 | 7.75 |
Lrrc55 |
leucine rich repeat containing 55 |
1296 |
0.28 |
chr7_44428104_44428935 | 7.74 |
Lrrc4b |
leucine rich repeat containing 4B |
499 |
0.58 |
chrX_58037918_58039258 | 7.74 |
Zic3 |
zinc finger protein of the cerebellum 3 |
7578 |
0.26 |
chr4_126465012_126466992 | 7.74 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2419 |
0.18 |
chr2_94240530_94242057 | 7.73 |
Mir129b |
microRNA 129b |
85 |
0.6 |
chr3_88831100_88832914 | 7.73 |
1500004A13Rik |
RIKEN cDNA 1500004A13 gene |
361 |
0.77 |
chr14_55028350_55028974 | 7.72 |
Ngdn |
neuroguidin, EIF4E binding protein |
7240 |
0.08 |
chr16_42339015_42340584 | 7.71 |
Gap43 |
growth associated protein 43 |
852 |
0.7 |
chr15_39198018_39199372 | 7.68 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
332 |
0.87 |
chr9_104569742_104570707 | 7.68 |
Cpne4 |
copine IV |
437 |
0.89 |
chr19_5297797_5299076 | 7.67 |
Gal3st3 |
galactose-3-O-sulfotransferase 3 |
105 |
0.9 |
chr19_7270532_7271202 | 7.67 |
Rcor2 |
REST corepressor 2 |
85 |
0.94 |
chr4_91374442_91375761 | 7.66 |
Elavl2 |
ELAV like RNA binding protein 1 |
1206 |
0.41 |
chr16_7039399_7040361 | 7.66 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
29966 |
0.27 |
chr8_9770297_9772011 | 7.65 |
Fam155a |
family with sequence similarity 155, member A |
7 |
0.79 |
chr2_70564530_70567543 | 7.65 |
Gad1 |
glutamate decarboxylase 1 |
341 |
0.83 |
chr14_4182195_4183376 | 7.65 |
Gm2974 |
predicted gene 2974 |
209 |
0.91 |
chrX_143930842_143933141 | 7.59 |
Dcx |
doublecortin |
1059 |
0.64 |
chr3_88458101_88459325 | 7.58 |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
163 |
0.88 |
chr10_34299043_34301066 | 7.58 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr13_78181011_78182180 | 7.58 |
Gm38604 |
predicted gene, 38604 |
1564 |
0.29 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.2 | 45.6 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
11.2 | 33.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
10.4 | 41.8 | GO:0061205 | paramesonephric duct development(GO:0061205) |
10.3 | 10.3 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
9.2 | 55.2 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
8.9 | 26.6 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
8.8 | 26.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
8.5 | 34.2 | GO:0007412 | axon target recognition(GO:0007412) |
8.2 | 24.5 | GO:0048880 | sensory system development(GO:0048880) |
8.1 | 40.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
7.9 | 23.8 | GO:0014016 | neuroblast differentiation(GO:0014016) |
7.9 | 15.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
7.7 | 23.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
7.5 | 15.1 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
7.3 | 14.6 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
7.0 | 35.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
6.6 | 19.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
6.6 | 52.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
6.6 | 13.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
6.6 | 26.2 | GO:0060594 | mammary gland specification(GO:0060594) |
6.4 | 32.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
6.3 | 25.4 | GO:0060174 | limb bud formation(GO:0060174) |
6.3 | 31.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
6.3 | 25.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
6.1 | 12.3 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
5.9 | 11.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
5.8 | 5.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
5.6 | 5.6 | GO:0021550 | medulla oblongata development(GO:0021550) |
5.5 | 16.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
5.5 | 16.4 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
5.4 | 16.2 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
5.4 | 16.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
5.4 | 16.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
5.3 | 42.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
5.1 | 20.5 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
5.1 | 10.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
5.0 | 20.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
5.0 | 20.0 | GO:0061743 | motor learning(GO:0061743) |
5.0 | 40.0 | GO:0071625 | vocalization behavior(GO:0071625) |
5.0 | 14.9 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
4.9 | 4.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
4.9 | 19.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
4.9 | 9.8 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
4.9 | 14.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
4.9 | 29.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
4.8 | 14.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
4.8 | 14.4 | GO:0072017 | distal tubule development(GO:0072017) |
4.8 | 4.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
4.7 | 9.4 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
4.7 | 14.2 | GO:0033058 | directional locomotion(GO:0033058) |
4.6 | 13.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
4.5 | 18.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
4.5 | 13.5 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
4.4 | 13.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.4 | 22.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
4.4 | 31.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
4.4 | 13.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.4 | 4.4 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
4.3 | 8.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
4.3 | 12.8 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
4.3 | 4.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
4.3 | 17.0 | GO:0046958 | nonassociative learning(GO:0046958) |
4.2 | 4.2 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
4.2 | 12.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
4.2 | 12.6 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
4.1 | 16.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
4.1 | 41.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
4.1 | 16.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
4.1 | 16.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
4.1 | 36.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
4.0 | 8.0 | GO:0021586 | pons maturation(GO:0021586) |
4.0 | 15.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
3.9 | 15.7 | GO:0021914 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.9 | 96.9 | GO:0001964 | startle response(GO:0001964) |
3.9 | 11.6 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
3.9 | 11.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
3.9 | 15.4 | GO:0030035 | microspike assembly(GO:0030035) |
3.8 | 7.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
3.8 | 11.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
3.8 | 11.4 | GO:0097503 | sialylation(GO:0097503) |
3.8 | 15.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
3.7 | 7.5 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
3.7 | 7.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
3.7 | 7.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
3.6 | 50.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
3.6 | 3.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
3.6 | 43.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
3.6 | 3.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
3.6 | 3.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
3.6 | 10.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
3.5 | 28.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
3.5 | 10.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.5 | 10.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
3.5 | 13.8 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
3.4 | 6.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
3.4 | 10.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
3.4 | 27.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
3.4 | 6.8 | GO:0060166 | olfactory pit development(GO:0060166) |
3.4 | 10.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
3.3 | 13.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
3.3 | 23.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
3.3 | 13.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
3.3 | 9.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
3.2 | 6.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
3.2 | 6.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
3.2 | 3.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
3.2 | 25.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.2 | 15.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
3.1 | 3.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.1 | 9.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
3.1 | 3.1 | GO:0086068 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
3.0 | 3.0 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
3.0 | 9.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
3.0 | 9.0 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
3.0 | 6.0 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
3.0 | 12.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
3.0 | 12.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.0 | 8.9 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
3.0 | 3.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
2.9 | 11.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
2.9 | 2.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
2.9 | 8.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.9 | 5.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.9 | 5.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
2.9 | 5.7 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
2.9 | 2.9 | GO:0072174 | metanephric tubule formation(GO:0072174) |
2.8 | 2.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
2.8 | 5.6 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
2.8 | 5.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
2.8 | 8.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
2.8 | 11.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
2.8 | 91.0 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
2.8 | 8.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.7 | 8.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.7 | 8.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.7 | 8.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
2.7 | 8.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.7 | 10.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.7 | 142.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.7 | 5.4 | GO:0072033 | renal vesicle formation(GO:0072033) metanephric renal vesicle formation(GO:0072093) |
2.7 | 8.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.7 | 74.5 | GO:0019228 | neuronal action potential(GO:0019228) |
2.6 | 5.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
2.6 | 15.8 | GO:0048840 | otolith development(GO:0048840) |
2.6 | 7.9 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
2.6 | 5.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
2.6 | 5.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.6 | 18.2 | GO:0021854 | hypothalamus development(GO:0021854) |
2.6 | 12.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
2.6 | 7.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.6 | 5.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
2.5 | 10.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
2.5 | 15.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
2.5 | 10.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.5 | 7.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.5 | 2.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
2.5 | 5.0 | GO:0090135 | actin filament branching(GO:0090135) |
2.5 | 12.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
2.4 | 2.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.4 | 9.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.4 | 29.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.4 | 4.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
2.4 | 2.4 | GO:0051593 | response to folic acid(GO:0051593) |
2.4 | 2.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
2.4 | 35.9 | GO:0035640 | exploration behavior(GO:0035640) |
2.4 | 9.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
2.4 | 14.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.4 | 7.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
2.4 | 4.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
2.4 | 21.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.3 | 9.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.3 | 9.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
2.3 | 11.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
2.3 | 11.4 | GO:0014028 | notochord formation(GO:0014028) |
2.3 | 4.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
2.3 | 2.3 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
2.3 | 18.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
2.2 | 4.5 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.2 | 4.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
2.2 | 11.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.2 | 11.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.2 | 13.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.2 | 8.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.2 | 4.4 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
2.2 | 4.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.2 | 17.2 | GO:0008038 | neuron recognition(GO:0008038) |
2.1 | 4.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.1 | 4.3 | GO:0009629 | response to gravity(GO:0009629) |
2.1 | 6.3 | GO:0030421 | defecation(GO:0030421) |
2.1 | 2.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
2.1 | 4.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
2.1 | 6.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.1 | 6.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.0 | 4.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
2.0 | 4.0 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
2.0 | 6.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
2.0 | 5.9 | GO:0048664 | neuron fate determination(GO:0048664) |
2.0 | 5.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
2.0 | 19.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
2.0 | 2.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.9 | 1.9 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.9 | 7.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.9 | 1.9 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
1.9 | 5.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.9 | 3.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
1.9 | 1.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.9 | 7.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.9 | 1.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.9 | 7.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.9 | 3.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.9 | 3.8 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.9 | 7.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.9 | 5.6 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.8 | 5.5 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.8 | 3.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.8 | 1.8 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.8 | 7.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.8 | 3.6 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.8 | 1.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.8 | 1.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.8 | 5.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.7 | 5.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.7 | 3.5 | GO:0030432 | peristalsis(GO:0030432) |
1.7 | 20.7 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
1.7 | 1.7 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
1.7 | 5.1 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
1.7 | 3.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.7 | 3.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.7 | 5.1 | GO:0030070 | insulin processing(GO:0030070) |
1.7 | 123.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.7 | 1.7 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
1.7 | 5.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.6 | 1.6 | GO:0051794 | regulation of catagen(GO:0051794) |
1.6 | 8.2 | GO:0035989 | tendon development(GO:0035989) |
1.6 | 1.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.6 | 11.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.6 | 3.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
1.6 | 1.6 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
1.6 | 3.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.6 | 3.2 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
1.6 | 6.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.6 | 9.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.6 | 11.3 | GO:0060384 | innervation(GO:0060384) |
1.6 | 4.8 | GO:0015817 | histidine transport(GO:0015817) |
1.6 | 3.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.6 | 1.6 | GO:0061055 | myotome development(GO:0061055) |
1.6 | 3.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.6 | 6.4 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
1.6 | 3.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.6 | 3.2 | GO:0090427 | activation of meiosis(GO:0090427) |
1.6 | 9.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.6 | 18.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.6 | 11.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.6 | 1.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.6 | 1.6 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
1.6 | 12.4 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
1.5 | 4.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.5 | 15.4 | GO:0021884 | forebrain neuron development(GO:0021884) |
1.5 | 15.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.5 | 6.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.5 | 3.0 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
1.5 | 9.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
1.5 | 1.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
1.5 | 6.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.5 | 12.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.5 | 6.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
1.5 | 25.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.5 | 4.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.5 | 11.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.5 | 2.9 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
1.5 | 7.3 | GO:0071599 | otic vesicle development(GO:0071599) |
1.5 | 2.9 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
1.5 | 1.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.5 | 4.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.5 | 5.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.4 | 4.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.4 | 5.7 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
1.4 | 5.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
1.4 | 14.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
1.4 | 11.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.4 | 5.7 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.4 | 7.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.4 | 4.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.4 | 11.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.4 | 4.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.4 | 7.0 | GO:0007614 | short-term memory(GO:0007614) |
1.4 | 9.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
1.4 | 2.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.4 | 5.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.4 | 2.8 | GO:0015888 | thiamine transport(GO:0015888) |
1.4 | 4.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.4 | 4.1 | GO:0035106 | operant conditioning(GO:0035106) |
1.4 | 23.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.4 | 1.4 | GO:0015744 | succinate transport(GO:0015744) |
1.4 | 42.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
1.4 | 5.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.3 | 5.4 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
1.3 | 1.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.3 | 14.8 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
1.3 | 4.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.3 | 4.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.3 | 4.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.3 | 14.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
1.3 | 3.9 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.3 | 1.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.3 | 3.9 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.3 | 14.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.3 | 2.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.3 | 10.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
1.3 | 3.8 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.3 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.3 | 1.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.2 | 5.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.2 | 5.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.2 | 8.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.2 | 1.2 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
1.2 | 3.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 3.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.2 | 2.4 | GO:0008306 | associative learning(GO:0008306) |
1.2 | 13.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
1.2 | 10.9 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
1.2 | 4.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.2 | 3.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.2 | 7.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.2 | 3.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.2 | 3.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.2 | 5.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.2 | 3.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.2 | 5.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.2 | 7.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.2 | 19.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.2 | 3.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.2 | 3.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.1 | 4.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
1.1 | 4.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
1.1 | 2.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.1 | 4.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.1 | 2.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.1 | 9.0 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
1.1 | 1.1 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
1.1 | 9.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
1.1 | 1.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.1 | 1.1 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.1 | 32.1 | GO:0008542 | visual learning(GO:0008542) |
1.1 | 18.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
1.1 | 5.5 | GO:0035878 | nail development(GO:0035878) |
1.1 | 90.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
1.1 | 3.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 12.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.1 | 3.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.1 | 5.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
1.1 | 4.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.1 | 1.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.1 | 2.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.1 | 54.5 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
1.1 | 1.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
1.1 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.1 | 2.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.1 | 13.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
1.1 | 4.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.1 | 3.2 | GO:0021794 | thalamus development(GO:0021794) |
1.0 | 3.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.0 | 4.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.0 | 2.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.0 | 5.1 | GO:0015884 | folic acid transport(GO:0015884) |
1.0 | 1.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.0 | 2.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.0 | 1.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.0 | 1.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.0 | 1.0 | GO:0060022 | hard palate development(GO:0060022) |
1.0 | 3.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
1.0 | 1.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
1.0 | 2.0 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
1.0 | 1.0 | GO:0048382 | mesendoderm development(GO:0048382) |
1.0 | 20.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
1.0 | 2.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.0 | 1.9 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.0 | 1.0 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.0 | 4.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
1.0 | 3.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.0 | 1.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.0 | 22.1 | GO:0010107 | potassium ion import(GO:0010107) |
1.0 | 1.9 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.0 | 12.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.0 | 4.8 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.0 | 12.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
1.0 | 1.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
1.0 | 2.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.9 | 2.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.9 | 2.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.9 | 1.9 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) |
0.9 | 0.9 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.9 | 0.9 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.9 | 2.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.9 | 12.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.9 | 1.8 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.9 | 2.8 | GO:0060023 | soft palate development(GO:0060023) |
0.9 | 0.9 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.9 | 0.9 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.9 | 0.9 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.9 | 9.0 | GO:0030901 | midbrain development(GO:0030901) |
0.9 | 0.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.9 | 2.7 | GO:0015747 | urate transport(GO:0015747) |
0.9 | 2.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.9 | 2.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.9 | 0.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.9 | 1.8 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.9 | 0.9 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.9 | 3.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.9 | 4.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.9 | 5.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.9 | 2.6 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
0.9 | 39.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.9 | 0.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.9 | 4.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.9 | 1.7 | GO:0021554 | optic nerve development(GO:0021554) |
0.9 | 4.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.9 | 7.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.8 | 0.8 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.8 | 6.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.8 | 5.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 1.7 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.8 | 1.7 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.8 | 3.4 | GO:0030903 | notochord development(GO:0030903) |
0.8 | 0.8 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.8 | 3.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.8 | 2.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.8 | 1.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 2.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.8 | 2.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 0.8 | GO:0010536 | positive regulation of activation of JAK2 kinase activity(GO:0010535) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.8 | 2.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.8 | 1.6 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.8 | 1.6 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.8 | 3.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.8 | 9.3 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.8 | 2.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 2.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.8 | 2.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 6.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.8 | 2.3 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.8 | 2.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.8 | 2.3 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.7 | 44.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.7 | 0.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.7 | 20.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.7 | 1.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.7 | 0.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.7 | 4.4 | GO:0032095 | regulation of response to food(GO:0032095) |
0.7 | 5.1 | GO:0060068 | vagina development(GO:0060068) |
0.7 | 0.7 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.7 | 2.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.7 | 5.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.7 | 8.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.7 | 0.7 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.7 | 1.4 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.7 | 1.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.7 | 3.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.7 | 7.7 | GO:0036065 | fucosylation(GO:0036065) |
0.7 | 1.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 1.4 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.7 | 1.4 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.7 | 0.7 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.7 | 6.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.7 | 2.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.7 | 4.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.7 | 6.0 | GO:0097484 | dendrite extension(GO:0097484) |
0.7 | 0.7 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.7 | 4.6 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.7 | 2.0 | GO:0003383 | apical constriction(GO:0003383) |
0.7 | 2.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.7 | 3.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 1.9 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 1.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.6 | 1.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.6 | 0.6 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.6 | 1.9 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.6 | 1.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 3.8 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.6 | 0.6 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.6 | 1.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.6 | 0.6 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.6 | 1.8 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.6 | 1.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.6 | 1.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.6 | 0.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 12.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.6 | 1.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.6 | 1.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 0.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 3.0 | GO:0007416 | synapse assembly(GO:0007416) |
0.6 | 3.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.6 | 1.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.6 | 1.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.6 | 1.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.6 | 0.6 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.6 | 1.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 0.6 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.6 | 14.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.6 | 4.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.6 | 1.2 | GO:0001757 | somite specification(GO:0001757) |
0.6 | 1.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.6 | 2.3 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.6 | 4.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.6 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.6 | 2.8 | GO:1903514 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.6 | 1.7 | GO:0042756 | drinking behavior(GO:0042756) |
0.6 | 3.4 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.6 | 1.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.6 | 1.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.6 | 1.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.6 | 0.6 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.6 | 1.7 | GO:0007379 | segment specification(GO:0007379) |
0.6 | 2.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 2.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 0.5 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 2.2 | GO:0043084 | penile erection(GO:0043084) |
0.5 | 0.5 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.5 | 8.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 0.5 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.5 | 1.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.5 | 1.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.5 | 29.6 | GO:0001764 | neuron migration(GO:0001764) |
0.5 | 0.5 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.5 | 1.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.5 | 1.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 7.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 0.5 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.5 | 0.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 3.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.5 | 3.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.5 | 0.5 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.5 | 1.0 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.5 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 3.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 0.5 | GO:0060157 | urinary bladder development(GO:0060157) |
0.5 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 1.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 3.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.5 | 2.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.5 | 1.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 0.5 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.5 | 0.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 2.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 0.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.5 | 1.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 0.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 0.9 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.5 | 1.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.5 | 3.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.5 | 1.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.5 | 9.9 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.5 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 1.3 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.4 | 1.3 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.4 | 0.9 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 2.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.4 | 4.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 4.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.4 | 0.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 3.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.4 | 0.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 2.1 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.4 | 0.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.4 | 2.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.4 | 0.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 0.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 1.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 1.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 2.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 1.2 | GO:0033504 | floor plate development(GO:0033504) |
0.4 | 1.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.4 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 2.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.4 | 0.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 0.4 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.4 | 0.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.4 | 0.8 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.4 | 1.6 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 1.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 3.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.4 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 0.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 0.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 0.8 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.4 | 8.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.4 | 1.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 1.5 | GO:0050655 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.4 | 1.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 0.7 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 1.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 0.4 | GO:0072087 | renal vesicle development(GO:0072087) |
0.4 | 1.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 3.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.4 | 1.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 0.4 | GO:0090175 | regulation of establishment of planar polarity(GO:0090175) |
0.4 | 1.8 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.4 | 0.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.4 | 21.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.4 | 1.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 1.0 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 4.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.3 | 0.7 | GO:0031000 | response to caffeine(GO:0031000) |
0.3 | 1.0 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 0.3 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.3 | 6.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.3 | 2.4 | GO:0015844 | monoamine transport(GO:0015844) |
0.3 | 1.0 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.3 | 0.7 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 3.3 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.3 | 0.7 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 3.6 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.3 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 4.8 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 0.6 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 0.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 0.9 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.3 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 1.9 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.9 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 3.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.3 | 0.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.3 | 2.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 2.7 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.3 | 0.9 | GO:0015872 | dopamine transport(GO:0015872) |
0.3 | 0.3 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.3 | 1.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 0.6 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.3 | 1.5 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.3 | 1.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 0.6 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.3 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 1.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.3 | 1.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 3.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.3 | 0.6 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 2.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 1.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.3 | 1.1 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.3 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 1.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 1.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 1.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 1.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 1.8 | GO:0030817 | regulation of cAMP biosynthetic process(GO:0030817) |
0.3 | 1.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 1.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.3 | 1.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.3 | 0.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.3 | 2.8 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.3 | 1.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 3.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.5 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 3.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.2 | 1.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.2 | 0.7 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 3.1 | GO:0007612 | learning(GO:0007612) |
0.2 | 0.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 18.1 | GO:0007601 | visual perception(GO:0007601) |
0.2 | 0.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 2.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.5 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.2 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.2 | 0.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 1.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 2.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 1.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.2 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 3.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 1.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 2.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.2 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 1.8 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 0.2 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.6 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.4 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 0.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 0.2 | GO:0060459 | left lung development(GO:0060459) |
0.2 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 0.2 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 4.6 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.2 | 0.2 | GO:0007632 | visual behavior(GO:0007632) |
0.2 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.5 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 4.9 | GO:0030900 | forebrain development(GO:0030900) |
0.2 | 0.3 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.2 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.3 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.3 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.9 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.7 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 3.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.9 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.4 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.8 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.3 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 3.4 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 1.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.6 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.8 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.1 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.1 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 6.2 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.2 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.1 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 1.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 2.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.2 | GO:0051875 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0030802 | regulation of cyclic nucleotide biosynthetic process(GO:0030802) |
0.1 | 0.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.1 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.1 | 1.1 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.1 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.0 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.0 | 0.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 18.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
5.7 | 56.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
5.2 | 20.9 | GO:0044308 | axonal spine(GO:0044308) |
4.8 | 29.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
4.8 | 52.3 | GO:0043194 | axon initial segment(GO:0043194) |
4.5 | 54.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
4.2 | 79.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
4.1 | 113.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.9 | 15.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.8 | 11.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
3.7 | 26.0 | GO:0032584 | growth cone membrane(GO:0032584) |
3.5 | 10.6 | GO:0072534 | perineuronal net(GO:0072534) |
3.5 | 20.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
3.4 | 17.2 | GO:0043083 | synaptic cleft(GO:0043083) |
3.4 | 10.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
3.3 | 3.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.0 | 3.0 | GO:0005883 | neurofilament(GO:0005883) |
3.0 | 12.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.9 | 120.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
2.9 | 8.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.9 | 20.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
2.7 | 16.1 | GO:0030673 | axolemma(GO:0030673) |
2.6 | 7.9 | GO:0044393 | microspike(GO:0044393) |
2.5 | 7.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.5 | 58.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
2.5 | 20.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.4 | 26.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.4 | 74.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.4 | 28.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
2.4 | 2.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.3 | 9.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.3 | 9.2 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.2 | 24.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.2 | 109.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.1 | 26.8 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.0 | 19.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.9 | 5.8 | GO:0000322 | storage vacuole(GO:0000322) |
1.9 | 5.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.8 | 3.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.7 | 17.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.7 | 50.6 | GO:0043198 | dendritic shaft(GO:0043198) |
1.6 | 6.6 | GO:0043203 | axon hillock(GO:0043203) |
1.6 | 161.7 | GO:0043204 | perikaryon(GO:0043204) |
1.6 | 3.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.6 | 1.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.6 | 4.7 | GO:0034706 | sodium channel complex(GO:0034706) |
1.5 | 6.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.5 | 12.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.5 | 1.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.5 | 4.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.5 | 4.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.5 | 9.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.4 | 15.8 | GO:0031045 | dense core granule(GO:0031045) |
1.4 | 27.3 | GO:0044295 | axonal growth cone(GO:0044295) |
1.4 | 2.8 | GO:0097441 | basilar dendrite(GO:0097441) |
1.4 | 5.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.4 | 11.1 | GO:0031527 | filopodium membrane(GO:0031527) |
1.4 | 8.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.3 | 168.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.3 | 1.3 | GO:0097513 | myosin II filament(GO:0097513) |
1.2 | 11.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.2 | 28.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.2 | 1.2 | GO:0044299 | C-fiber(GO:0044299) |
1.2 | 4.7 | GO:0071953 | elastic fiber(GO:0071953) |
1.1 | 3.4 | GO:1990696 | USH2 complex(GO:1990696) |
1.1 | 4.5 | GO:0061574 | ASAP complex(GO:0061574) |
1.1 | 11.1 | GO:0005921 | gap junction(GO:0005921) |
1.1 | 1.1 | GO:0044298 | cell body membrane(GO:0044298) |
1.1 | 5.5 | GO:0071547 | piP-body(GO:0071547) |
1.0 | 7.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.0 | 20.6 | GO:0005922 | connexon complex(GO:0005922) |
1.0 | 3.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.0 | 4.0 | GO:0097433 | dense body(GO:0097433) |
1.0 | 27.0 | GO:0031941 | filamentous actin(GO:0031941) |
1.0 | 1.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.9 | 0.9 | GO:0097386 | glial cell projection(GO:0097386) |
0.9 | 3.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 0.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.9 | 7.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.9 | 2.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.9 | 7.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.8 | 2.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 1.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.8 | 8.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 46.6 | GO:0043679 | axon terminus(GO:0043679) |
0.8 | 2.3 | GO:1990393 | 3M complex(GO:1990393) |
0.8 | 2.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.8 | 1.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.7 | 3.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.7 | 1.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.7 | 3.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 2.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 1.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 4.3 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 5.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 2.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.7 | 95.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 2.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 2.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.7 | 22.0 | GO:0030175 | filopodium(GO:0030175) |
0.6 | 39.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.6 | 3.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.6 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 5.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.6 | 3.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.6 | 1.7 | GO:0000802 | transverse filament(GO:0000802) |
0.6 | 1.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 140.7 | GO:0045202 | synapse(GO:0045202) |
0.6 | 5.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 9.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.5 | 9.1 | GO:0030315 | T-tubule(GO:0030315) |
0.5 | 7.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 1.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 1.8 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 0.9 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 3.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 1.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 106.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.4 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 12.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 8.2 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 8.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 1.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 2.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.3 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 106.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 1.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 3.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 1.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 2.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.3 | 3.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 3.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 3.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 3.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 92.1 | GO:0043005 | neuron projection(GO:0043005) |
0.3 | 2.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.0 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 4.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 2.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 22.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 4.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 3.1 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 1.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 0.7 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 2.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 1.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 6.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 6.7 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 2.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 4.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 3.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 3.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 0.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.2 | GO:0005839 | proteasome core complex(GO:0005839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 45.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
7.2 | 28.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
7.2 | 21.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
7.2 | 21.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
7.0 | 35.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
6.5 | 19.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
5.7 | 39.7 | GO:0003680 | AT DNA binding(GO:0003680) |
5.7 | 5.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
5.6 | 16.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
5.5 | 38.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
5.4 | 5.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
5.2 | 10.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
4.8 | 19.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.6 | 13.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
4.6 | 27.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
4.4 | 34.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
4.3 | 12.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
4.2 | 12.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
4.1 | 16.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
4.0 | 12.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
3.8 | 18.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.7 | 11.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
3.7 | 11.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
3.7 | 47.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
3.6 | 3.6 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
3.6 | 39.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
3.6 | 42.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
3.5 | 17.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.5 | 28.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
3.5 | 10.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.4 | 13.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.2 | 25.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
3.1 | 12.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.9 | 11.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.9 | 8.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.9 | 20.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
2.9 | 17.5 | GO:0008066 | ionotropic glutamate receptor activity(GO:0004970) glutamate receptor activity(GO:0008066) |
2.9 | 23.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.9 | 20.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.9 | 11.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.8 | 8.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
2.8 | 58.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.7 | 8.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.7 | 5.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
2.7 | 34.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
2.6 | 13.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.6 | 12.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.5 | 12.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.5 | 15.2 | GO:0048495 | Roundabout binding(GO:0048495) |
2.5 | 32.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
2.5 | 7.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.4 | 9.7 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
2.4 | 7.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
2.3 | 9.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.3 | 46.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.3 | 68.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.3 | 27.3 | GO:0031005 | filamin binding(GO:0031005) |
2.2 | 9.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.2 | 8.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
2.2 | 11.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
2.1 | 10.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.1 | 6.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.1 | 10.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
2.1 | 10.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.0 | 8.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.0 | 46.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.0 | 28.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
2.0 | 8.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.0 | 2.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
2.0 | 26.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
2.0 | 7.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.9 | 9.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.9 | 3.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.9 | 5.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.9 | 9.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.9 | 9.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.9 | 30.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.8 | 7.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.8 | 5.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.8 | 9.2 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.8 | 23.6 | GO:0035198 | miRNA binding(GO:0035198) |
1.8 | 18.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.8 | 12.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.8 | 7.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.8 | 5.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.7 | 45.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.7 | 5.2 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.7 | 8.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
1.7 | 5.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.7 | 3.4 | GO:0043121 | neurotrophin binding(GO:0043121) |
1.7 | 3.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.7 | 5.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.6 | 4.9 | GO:0070052 | collagen V binding(GO:0070052) |
1.6 | 13.1 | GO:0038191 | neuropilin binding(GO:0038191) |
1.6 | 4.9 | GO:0034956 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
1.6 | 8.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.6 | 4.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.6 | 16.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.6 | 4.8 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.6 | 1.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
1.6 | 7.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.5 | 4.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.5 | 34.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.5 | 27.0 | GO:0005112 | Notch binding(GO:0005112) |
1.5 | 22.0 | GO:0015026 | coreceptor activity(GO:0015026) |
1.4 | 11.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.4 | 10.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.4 | 4.2 | GO:0051373 | FATZ binding(GO:0051373) |
1.4 | 8.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.4 | 19.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
1.4 | 42.8 | GO:0005109 | frizzled binding(GO:0005109) |
1.4 | 13.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
1.4 | 1.4 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
1.4 | 4.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.4 | 2.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.3 | 5.4 | GO:0097001 | ceramide binding(GO:0097001) |
1.3 | 38.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.3 | 18.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.3 | 10.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.3 | 17.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.3 | 13.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.3 | 3.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.3 | 3.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.3 | 5.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.2 | 2.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.2 | 2.5 | GO:0030553 | cGMP binding(GO:0030553) |
1.2 | 23.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.2 | 13.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.2 | 1.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.2 | 4.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.2 | 8.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
1.2 | 4.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.2 | 14.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.2 | 14.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.2 | 3.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.2 | 3.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.2 | 46.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.2 | 4.6 | GO:0038132 | neuregulin binding(GO:0038132) |
1.1 | 1.1 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
1.1 | 37.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.1 | 3.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.1 | 7.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.1 | 14.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.1 | 1.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
1.1 | 4.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.1 | 2.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.1 | 13.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.1 | 13.9 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
1.1 | 21.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.1 | 2.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.0 | 10.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.0 | 11.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.0 | 6.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.0 | 23.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.0 | 3.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.0 | 5.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.0 | 2.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.0 | 1.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 7.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.0 | 1.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.0 | 13.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.0 | 2.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.9 | 4.7 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 9.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.9 | 1.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.9 | 1.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 32.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.9 | 2.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.9 | 13.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.9 | 10.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 2.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.9 | 3.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.9 | 8.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.9 | 1.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.9 | 3.6 | GO:0070888 | E-box binding(GO:0070888) |
0.9 | 18.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.9 | 10.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.9 | 2.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.9 | 1.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.9 | 14.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.9 | 7.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.9 | 1.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 4.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.8 | 13.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.8 | 7.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.8 | 3.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.8 | 17.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 4.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 6.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.8 | 7.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.8 | 1.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.8 | 6.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.8 | 7.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.8 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.8 | 3.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.8 | 17.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.8 | 3.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 8.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.8 | 20.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.7 | 2.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 0.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.7 | 2.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 4.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.7 | 3.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 2.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.7 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.7 | 2.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.7 | 27.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.7 | 2.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.7 | 0.7 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.7 | 18.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.7 | 17.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.7 | 2.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.7 | 8.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.7 | 2.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.7 | 0.7 | GO:0005119 | smoothened binding(GO:0005119) |
0.7 | 1.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.6 | 5.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 3.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 1.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 3.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.6 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.6 | 8.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.6 | 2.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 3.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.6 | 2.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.6 | 8.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.6 | 2.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 1.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 2.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 55.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.6 | 10.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 0.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.5 | 2.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 1.6 | GO:0004103 | choline kinase activity(GO:0004103) |
0.5 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 1.6 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.5 | 5.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.5 | 6.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.5 | 1.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 3.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 2.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.5 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 8.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 2.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 5.4 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 28.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.5 | 103.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.5 | 2.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 2.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 4.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 10.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 1.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 1.8 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 2.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 6.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 1.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 1.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 1.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 0.8 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 3.7 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.4 | 1.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.4 | 1.6 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.4 | 2.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 0.8 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.4 | 1.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 1.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 2.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.4 | 1.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 1.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 3.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 13.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 7.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 1.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 1.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 2.1 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.3 | 146.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 4.4 | GO:0052859 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.3 | 2.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 1.0 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 1.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 2.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 6.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 10.6 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 3.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 0.3 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 2.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 6.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.3 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 5.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 41.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.3 | 179.6 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 0.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 2.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 1.1 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 1.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 3.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 6.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 4.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.2 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 2.4 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 1.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 1.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 3.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.4 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 5.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 2.7 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 8.8 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.4 | GO:0018642 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 3.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.2 | 3.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 1.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 1.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 3.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 1.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 2.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 2.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 1.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.7 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 2.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 6.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.4 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 2.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 7.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.2 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 1.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 1.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 2.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 1.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 16.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 1.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 67.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.9 | 26.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.9 | 60.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.6 | 3.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.6 | 61.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.4 | 21.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.3 | 21.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.3 | 22.5 | PID REELIN PATHWAY | Reelin signaling pathway |
1.2 | 35.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.2 | 5.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.1 | 14.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.1 | 28.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.1 | 23.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.0 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
1.0 | 11.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.0 | 1.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 15.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.9 | 19.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.9 | 8.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.9 | 36.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.8 | 9.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 18.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.7 | 8.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.7 | 8.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.7 | 22.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 1.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.6 | 12.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.6 | 100.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.6 | 7.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 2.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 1.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 12.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 11.6 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 38.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 15.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 65.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 6.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 38.3 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.2 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 4.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 4.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 49.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
4.6 | 68.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
3.5 | 49.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
3.4 | 33.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.3 | 43.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
3.3 | 45.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.0 | 3.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
3.0 | 33.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
3.0 | 35.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.9 | 125.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.7 | 21.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.4 | 75.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.3 | 25.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.2 | 49.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.1 | 33.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.9 | 7.6 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
1.9 | 73.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.8 | 19.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.8 | 17.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.7 | 19.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.7 | 5.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
1.6 | 6.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.6 | 33.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
1.5 | 29.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.5 | 34.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.4 | 5.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.3 | 109.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.3 | 3.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
1.2 | 13.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.2 | 22.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.2 | 19.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.2 | 14.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.1 | 13.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
1.0 | 1.9 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.9 | 2.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.9 | 11.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.9 | 0.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.9 | 12.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 18.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.8 | 30.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.8 | 40.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.8 | 9.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.8 | 22.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.7 | 2.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.7 | 7.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.7 | 4.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 13.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.7 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.6 | 8.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.6 | 2.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.6 | 1.7 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.6 | 7.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 8.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 79.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 8.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 5.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 3.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 9.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.4 | 5.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 3.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 8.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.4 | 0.7 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.3 | 7.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 8.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 4.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 3.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 1.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 12.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.3 | 2.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 3.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 1.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 1.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 1.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 1.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.2 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 2.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |